Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Mammography Market is Segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Mammography Market Bar Graph
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.13 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The mammography market is projected to register a CAGR of 9.13% during the forecast period, with a revenue of approximately USD 1,825.07 million in 2020, and it is expected to reach USD 3,215 million by 2026.

The COVID-19 pandemic has been continuing to transform the growth of various markets, the immediate impact of the outbreak is varied. While a few industries registered a drop in demand, numerous other markets may continue to remain unscathed and show promising growth opportunities. Initially, the COVID-19 outbreak showed a strong impact on the mammography market because hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the world. As many hospitals and screening centers remain closed due to lockdowns, the demand for mammography procedures is expected to be subdued in the short term. According to an article appearing in the JAMA Network in August 2020, there has been a significant decline in breast cancer diagnoses (by as much as 51.8%) in the United States from March 1, 2020, to April 18, 2020. Thus, this is expected to have a negative impact on mammography device manufacturers, as their demand has reduced significantly.

Moreover, the major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in breast imaging, and investment from various organizations in breast cancer screening campaigns.

According to the Centers for Disease Control and Prevention (CDC) reports 2018, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third-most-common cause of death from cancer among American Indian/Alaska Native women.

According to a Globocan report in 2020, breast cancer was the most prevalent type of cancer, with a prevalence rate of 11.7%. According to the same report, the five-year prevalence rate for both the sexes showed that Asia had the highest number of people affected at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%) and North America with 1.189,111 people (15.3%). Such high prevalence rates of breast cancer are one of the main reasons the demand for mammography devices is expected to increase, as they may be used for diagnostic purposes. Furthermore, as the global population is aging, a large number of women are expected to move into the age of 60 years and above. Women aged 60 years and above account for almost 78% of all breast cancer-related deaths. High incidence and mortality rates for breast cancer in this age group represent a huge unmet need for breast cancer diagnostics. As the number of incidents and mortality cases increases, the demand for mammography is also expected to increase. This remains a major driver for the mammography market and is expected to boost the market during the forecast period.

However, adverse effects from radiation exposure and risks associated with mammography are expected to pull back the market growth over the forecast period.

Scope of the Report

As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. The mammography market is segmented by product type (digital systems, analog systems, breast tomosynthesis, and other product types), end users (hospitals, specialty clinics, and diagnostic centers), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product Type
Digital Systems
Analog Systems
Breast Tomosynthesis
Other Product Types
By End Users
Specialty Clinics
Diagnostic Centers
By Geography
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Digital Mammography Segment is Expected to Account for the Largest Market Share During the Forecast Period

As breast cancer patients are at higher risk of acquiring the infection, many organizations took definite measures to manage these diseases. According to a research article by Dafina Petrova et al., published in Medicina Clínica Journal September 2020, the European Society for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEOR), and the Spanish Society of Medical Oncology (SEOM) have published some recommendations on how to modify treatment protocols to minimize risks in cancer patients. Such instances are expected to support the growth of the digital mammography market.

Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. So far, conventional screen-film mammography (SFM) with the high-spatial-resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with the added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as the United Kingdom, is now digital, offering greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.

Moreover, as per the American Cancer Society, in 2019, there were around 8,130 Ductal carcinomas in situ (DCIS) and 37,150 invasive breast cancer new cases among females aged between 40 to 49 years reported in the United States. Thus, the rising prevalence of breast cancer is likely to boost the demand for digital mammography.

Mammography Market Key Trends

North America Accounts for the Largest Share in the Global Market

North America is found to hold a major share of the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.

Due to the outbreak of COVID-19, the market is expected to face a slight setback owing to the delay in diagnosis, drug shortages, and others. However, as lockdowns and restrictions are getting relaxed, there may be an increase in demand for mammography services. Many women who had canceled their appointments or had their visits for mammography services postponed are now able to get their tests done. The Breast Cancer Research Foundation in the United States has stated that hospitals and facilities in most places are well prepared and safe now as compared to the initial days of the COVID-19 pandemic. Thus, it has been encouraging women to get their scheduled scans done so that diagnosis is not delayed.

According to the American Cancer Society, in 2020, an estimated 276,480 new cases of invasive breast cancer have been diagnosed among women. Additionally, 48,530 cases of in situ breast carcinoma have been diagnosed among women, and the number of breast cancer cases is expected to increase in the coming years. Furthermore, several companies are found launching programs to support breast cancer tests. For example, in August 2020, Hologic Inc. announced the Back to Screening campaign launch, which may encourage women to schedule their delayed mammograms due to the COVID-19 pandemic. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond The Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth over the forecast period.

Mammography Market Growth Rate By Region

Competitive Landscape

The mammography market is a consolidated one, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.

Recent Developments

  • In November 2020, Hologic Inc. and RadNet announced a collaboration to advance the development of artificial intelligence tools in breast health. The collaboration may include data sharing, R&D, and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology.
  • In September 2020, GE Healthcare and Candelis Inc. announced a collaboration to enhance mammography workflow, image management, and storage capabilities for the Senographe Pristina Mammography System.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Breast Cancer

      2. 4.2.2 Technological Advancements in the Field of Breast Imaging

      3. 4.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Adverse Effects from Radiation Exposure

      2. 4.3.2 Reduction in Reimbursement

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Digital Systems

      2. 5.1.2 Analog Systems

      3. 5.1.3 Breast Tomosynthesis

      4. 5.1.4 Other Product Types

    2. 5.2 By End Users

      1. 5.2.1 Hospitals

      2. 5.2.2 Specialty Clinics

      3. 5.2.3 Diagnostic Centers

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Fujifilm Holdings Corporation

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Hologic Inc.

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Planmed Oy

      6. 6.1.6 Siemens Healthineers

      7. 6.1.7 Carestream Health

      8. 6.1.8 Canon Medical Systems Corporation

      9. 6.1.9 Toshiba Medical Systems

      10. 6.1.10 Mindray Medical International Limited

      11. 6.1.11 Quest Diagnostics Incorporated

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Mammography Market market is studied from 2018 - 2026.

The Mammography Market is growing at a CAGR of 9.13% over the next 5 years.

The Mammography Market is valued at 1825 Million USD in 2018.

The Mammography Market is valued at 3060 Million USD in 2026.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, Siemens Healthineers are the major companies operating in Mammography Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!